Delivering genetic material with precision

Transfection introduces exogenous nucleic acids — plasmid DNA, mRNA, siRNA or ribonucleoprotein (RNP) complexes — into eukaryotic cells without viral vectors. Unlike transduction (viral delivery) or transformation (bacteria), it relies on physical, chemical or lipid-mediated strategies to overcome the cell membrane.

The goal is functional delivery: the cargo must reach its intracellular site of action intact and bioactive. DNA must survive nucleases, cross the nuclear envelope and be transcribed. siRNA must load into the RNA-induced silencing complex (RISC). CRISPR RNPs need rapid cytoplasmic access to cleave DNA before they degrade.

Cell type is the single most influential variable. Immortalized lines like HEK293 or CHO-K1 have robust endocytic activity and tolerate many reagents. Primary, stem and non-dividing cells have tighter membrane regulation, lower endocytic rates and heightened sensitivity to chemical stress — gentler reagents such as FuGENE HD or physical methods like nucleofection may be necessary.

The payload narrows the options further. Plasmid DNA (~3–10 kb) needs carriers that condense and protect it. siRNA and miRNA are smaller but must avoid degradation and reach RISC quickly. Delivering Cas9 as mRNA requires translation, while pre-assembled RNP gives faster, cleaner editing with fewer off-target effects — but demands reagents that can carry protein–RNA complexes.

The goal shapes the choice too: transient expression and screening prize efficiency, stable cell lines need low multi-day cytotoxicity, and therapeutic development puts endotoxin-free, GMP-grade compliance first. Finally, consider scalability — a reagent that works in a 24-well plate may fail in a bioreactor — and serum compatibility, which cuts hands-on time in automated workflows.

Start with healthy, low-passage cells plated to 70–90% confluency at the time of transfection. Over-confluent cells transfect poorly due to contact inhibition; sparse cultures may not survive the stress.

The nucleic acid-to-reagent ratio is the most critical parameter. Too little reagent leaves cargo uncomplexed; too much adds excess positive charge that damages membranes. Run a matrix titration — varying both DNA/RNA amount and reagent volume at constant cell number — and monitor expression (fluorescence, qPCR) and viability (ATP-based assays) at 24, 48 and 72 h.

Lipid reagents usually need serum-free buffers such as Opti-MEM during complex formation, then can be added to serum-containing cultures. Pre-warm reagents to 37 °C. Plasmid expression peaks at 48–72 h, siRNA knockdown around 48 h, and CRISPR phenotypes often need 72–96 h because of protein half-life.